CytaluxActive Ingredient(s): Pafolacianine Sodium
FDA Approved: * November 29, 2021
Pharm Company: * ON TARGET LABS
Category: Diagnostic Aid
Pafolacianine, sold under the brand name Cytalux, is an optical imaging agent. The most common side effects of pafolacianine include infusion-related reactions, including nausea, vomiting, abdominal pain, flushing, dyspepsia, chest discomfort, itching and hypersensitivity. It was approved for medical use in the United States in November 2021. ... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.